PubMed-indexed research reference found for Hydrazine Sulfate in relation to cancer or oncology.
Hydrazine Sulfate
Chemical promoted for cancer cachexia and as a metabolic anticancer agent that may interfere with tumor glucose use. Hydrazine sulfate has been studied for cancer and cancer-related cachexia. NCI PDQ states randomized trials did not show tumor shrinkage, cachexia results are inconclusive, animal studies suggest carcinogenicity, and FDA has not approved it for cancer treatment.
PubMed-indexed research reference found for Hydrazine Sulfate in relation to cancer or oncology.
PubMed-indexed research reference found for Hydrazine Sulfate in relation to cancer or oncology.
NCI CAM index used to identify missing PDQ topics including 714-X, antineoplastons, Cancell, cartilage, Gonzalez regimen, hydrazine sulfate, and Newcastle disease virus.
NCI professional summary: no anticancer activity in randomized trials, inconclusive cachexia evidence, animal carcinogenicity, not FDA-approved for cancer.